DLA Piper advised Ghost Robotics on the deal. Ghost Robotics, a leader in legged robotics, closed a strategic partnership with LIG Nex1, a South Korean defense...
Ghost Robotics’ Partnership with LIG Nex1
ANI Pharmaceuticals’ Acquisition of Alimera Sciences
Hughes Hubbard & Reed advised ANI, while DLA Piper advised Alimera Sciences on the deal. Alimera Sciences, Inc., a global pharmaceutical company focused on ophthalmic solutions,...
BillingPlatform’s US$90 Million Equity Growth Investment
DLA Piper represented BillingPlatform in the transaction. BillingPlatform, an enterprise revenue lifecycle management solutions provider, secured a significant US$90 million growth equity investment from FTV Capital, a...
Marlin Equity Partners’ Investment in TRAFiX
DLA Piper advised TRAFiX, while Goodwin Proctor advised Marlin on the deal. TRAFiX, a leading provider of order and execution management software (OEMS) and FIX connectivity...
GAN Integrity’s Series C Financing Round
DLA Piper advised GAN Integrity Holdings on the transaction. GAN Integrity Holdings (“GAN”), a pioneer of no-code risk, ethics, and compliance management technology, announced its Series C...
Liquidia’s US$100 Million Revenue Interest Financing Agreement
DLA Piper represented Liquidia Corporation in the transaction. Liquidia Corporation executed its revenue interest financing agreement with HealthCare Royalty, a leading royalty acquisition company focused on commercial...
Liquidia’s $50 Million Common Stock Offering
DLA Piper represented Liquidia, while Latham & Watkins represented the underwriters in the offering. Liquidia Corporation, a biopharmaceutical company focused on the development and commercialization of...